Ticker: TSHA

Company: Taysha Gene Therapies, Inc.

Person: Sukumar Nagendran, director, officer

Transaction date: Jan. 23, 2026

Reporting date: Jan. 27, 2026

Average share price: 4.717526755708746

Sold 116050.0 shares for 547468.98